Efficacy of Subcutaneous Bortezomib in the Management of Patients with Multiple Myeloma or Relapsed Mantle Cell Lymphoma

• Published in: Clinical Medicine Insights: Therapeutics Vol. 2014; no. 6; pp. 15 - 23
• Main Author: Podar, Klaus
• Format: Journal Article Book Review
• Language: English
• Published: London, England Libertas Academica 27.02.2014; SAGE Publishing; SAGE Publications; Sage Publications Ltd. (UK); Sage Publications Ltd
• Subjects: Bortezomib; Drug therapy; Health aspects; Lymphomas; Multiple myeloma; Patient outcomes; bortezomib; multiple myeloma; drug administration

The identification of the ubiquitin–proteasome system as a new therapeutic target has been one of the most recent successes in cancer treatment. The development and clinical approval of the first-in-class proteasome inhibitor, bortezomib has revolutionized the treatment of multiple myeloma (MM) and...